Conveners
Experiments - Non-LHC
- Jan-Hendrik Arling (Deutsches Elektronen-Synchrotron (DESY))
The proposed Circular Electron Positron Collider (CEPC) imposes new challenges for the vertex detector in terms of pixel size and material budget. A Monolithic Active Pixel Sensor (MAPS) prototype, TaichuPix, based on a data-driven structure and a column drain readout architecture, has been implemented to achieve high spatial resolution and fast readout. In order to verify the spatial...
In high-energy physics, upgrades for particle detectors and studies on future particle detectors are largely based on silicon sensors as tracking devices. The surface that needs to be covered by silicon sensors is constantly increasing so that they become an immense cost driver in particle physics experiments.
Consequently, there is a need to investigate new silicon sensor concepts that can...
MIMOSIS is a Monolithic Active Pixel Sensor (MAPS) designed in CIS Tower Jazz 180 nm technology for the Micro Vertex Detector (MVD) of the CBM heavy ion experiment at FAIR/GSI. In addition, its characteristics pave the road toward sensors equipping future Higgs factories. It is also anticipated to equip beam telescopes and various devices developed in the framework of the HORIZON 2020 large...
A strong effort is ongoing to find ecological alternative gas mixtures to be used for Resistive Plate Chambers (RPCs). RPCs are widely used in present LHC experiments and in other applications. Main gases used for proper RPC operations in avalanche mode are Tetrafluorethane (usually called R134a) and SF6. Both these gases have high Global Warming Potential and the community is starting...
Recent developments in accelerator technolgies have led to an increasing interest in electron accelerators for the purpose of radiation therapy. In the context of FLASH radiotherapy, collimated electron beams with a kinetic energy in the order of 50 to 250 MeV are utilized with the prospect of reducing the damage to healthy tissue with respect to conventional electron radiotherapy.
This...
